C000203168 Holdings — EQ/T. Rowe Price Health Sciences Portfolio
All 179 reported holdings of EQ/T. Rowe Price Health Sciences Portfolio (C000203168) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co. | 14.34% | $25.33M |
| Johnson & Johnson | 6.34% | $11.19M |
| UnitedHealth Group, Inc. | 5.98% | $10.56M |
| AbbVie, Inc. | 5.31% | $9.37M |
| Merck & Co., Inc. | 4.25% | $7.50M |
| Gilead Sciences, Inc. | 2.96% | $5.23M |
| Thermo Fisher Scientific, Inc. | 2.67% | $4.71M |
| Vertex Pharmaceuticals, Inc. | 2.39% | $4.22M |
| Bristol-Myers Squibb Co. | 2.24% | $3.95M |
| Abbott Laboratories | 2.01% | $3.56M |
| Intuitive Surgical, Inc. | 1.99% | $3.51M |
| Amgen, Inc. | 1.92% | $3.39M |
| Stryker Corp. | 1.89% | $3.34M |
| Elevance Health, Inc. | 1.62% | $2.86M |
| Danaher Corp. | 1.50% | $2.66M |
| Natera, Inc. | 1.50% | $2.65M |
| Guardant Health, Inc. | 1.30% | $2.29M |
| Invesco Govt And Agcy Lex | 1.28% | $2.27M |
| Cardinal Health, Inc. | 1.10% | $1.95M |
| Royalty Pharma plc | 1.02% | $1.81M |
| Tenet Healthcare Corp. | 1.00% | $1.76M |
| CVS Health Corp. | 0.99% | $1.74M |
| Kymera Therapeutics, Inc. | 0.94% | $1.66M |
| Protagonist Therapeutics, Inc. | 0.90% | $1.60M |
| Moderna, Inc. | 0.88% | $1.55M |
| BrightSpring Health Services, Inc. | 0.88% | $1.55M |
| Revolution Medicines, Inc. | 0.84% | $1.48M |
| Roivant Sciences Ltd. | 0.76% | $1.34M |
| Alnylam Pharmaceuticals, Inc. | 0.73% | $1.29M |
| Viatris, Inc. | 0.69% | $1.21M |
| Charles River Laboratories International, Inc. | 0.65% | $1.16M |
| Argenx SE | 0.63% | $1.12M |
| Edwards Lifesciences Corp. | 0.62% | $1.10M |
| Centene Corp. | 0.62% | $1.09M |
| Spyre Therapeutics, Inc. | 0.57% | $1.00M |
| Definium Therapeutics, Inc. | 0.54% | $949.83K |
| Insmed, Inc. | 0.53% | $930.58K |
| Chugai Pharmaceutical Co. Ltd. | 0.51% | $898.20K |
| Twist Bioscience Corp. | 0.51% | $895.06K |
| AstraZeneca plc | 0.49% | $864.29K |
| Boston Scientific Corp. | 0.48% | $843.95K |
| United Therapeutics Corp. | 0.47% | $824.12K |
| Krystal Biotech, Inc. | 0.46% | $820.28K |
| Medtronic plc | 0.46% | $813.59K |
| Erasca, Inc. | 0.42% | $741.96K |
| Mirum Pharmaceuticals, Inc. | 0.41% | $727.00K |
| Billiontoone, Inc. | 0.40% | $714.84K |
| Praxis Precision Medicines, Inc. | 0.40% | $705.40K |
| BeOne Medicines Ltd. | 0.40% | $699.27K |
| Tango Therapeutics, Inc. | 0.39% | $687.47K |
| Ascendis Pharma A/S | 0.39% | $685.47K |
| Monte Rosa Therapeutics, Inc. | 0.39% | $680.38K |
| Scholar Rock Holding Corp. | 0.38% | $670.56K |
| Medpace Holdings, Inc. | 0.38% | $669.93K |
| Humana, Inc. | 0.38% | $667.33K |
| Dianthus Therapeutics, Inc. | 0.38% | $667.06K |
| Oruka Therapeutics, Inc. | 0.38% | $663.05K |
| Kodiak Sciences, Inc. | 0.35% | $620.13K |
| Axsome Therapeutics, Inc. | 0.33% | $582.31K |
| Summit Therapeutics, Inc. | 0.33% | $577.76K |
| Novo Nordisk A/S | 0.32% | $566.84K |
| Regeneron Pharmaceuticals, Inc. | 0.31% | $547.47K |
| Cytokinetics, Inc. | 0.31% | $547.52K |
| MBX Biosciences, Inc. | 0.31% | $544.55K |
| Ionis Pharmaceuticals, Inc. | 0.31% | $543.30K |
| CG oncology, Inc. | 0.31% | $541.54K |
| Vera Therapeutics, Inc. | 0.30% | $532.17K |
| Relay Therapeutics, Inc. | 0.29% | $514.69K |
| Kailera Therapeutics, Inc. | 0.29% | $513.45K |
| Enliven Therapeutics, Inc. | 0.29% | $509.89K |
| Nurix Therapeutics, Inc. | 0.29% | $506.62K |
| Agilent Technologies, Inc. | 0.29% | $504.75K |
| Crinetics Pharmaceuticals, Inc. | 0.28% | $499.22K |
| Newamsterdam Pharma Co. NV | 0.27% | $484.63K |
| Madrigal Pharmaceuticals, Inc. | 0.27% | $483.25K |
| Waters Corp. | 0.27% | $480.05K |
| Rhythm Pharmaceuticals, Inc. | 0.27% | $472.21K |
| West Pharmaceutical Services, Inc. | 0.26% | $466.70K |
| Liquidia Corp. | 0.26% | $457.49K |
| Beam Therapeutics, Inc. | 0.26% | $452.13K |
| Bridgebio Pharma, Inc. | 0.25% | $444.72K |
| Ideaya Biosciences, Inc. | 0.24% | $425.44K |
| Teva Pharmaceutical Industries Ltd. | 0.24% | $423.50K |
| Viridian Therapeutics, Inc. | 0.24% | $416.45K |
| Alkermes plc | 0.23% | $413.92K |
| Immunome, Inc. | 0.23% | $408.97K |
| Alignment Healthcare, Inc. | 0.22% | $396.58K |
| Vaxcyte, Inc. | 0.22% | $380.87K |
| Immunocore Holdings plc | 0.21% | $365.98K |
| Rapport Therapeutics, Inc. | 0.20% | $358.53K |
| Palvella Therapeutics, Inc. | 0.20% | $347.67K |
| Structure Therapeutics, Inc. | 0.20% | $347.14K |
| Climb Bio, Inc. | 0.19% | $334.14K |
| ICON plc | 0.19% | $330.05K |
| Seaport Therapeutics, Inc. | 0.18% | $321.85K |
| Dreyfus Treasury & Agency Lex | 0.17% | $300.00K |
| Bicara Therapeutics, Inc. | 0.16% | $289.39K |
| Sonova Holding AG | 0.16% | $288.33K |
| ORIC Pharmaceuticals, Inc. | 0.16% | $286.18K |
| Celldex Therapeutics, Inc. | 0.16% | $275.50K |
| MoonLake Immunotherapeutics | 0.15% | $272.85K |
| Cencora, Inc. | 0.15% | $269.68K |
| Alumis, Inc. | 0.15% | $262.41K |
| Apogee Therapeutics, Inc. | 0.15% | $256.97K |
| Stoke Therapeutics, Inc. | 0.14% | $254.95K |
| Veeva Systems, Inc. | 0.14% | $248.46K |
| Cogent Biosciences, Inc. | 0.14% | $240.40K |
| Biohaven Ltd. | 0.13% | $238.05K |
| Generate Biomedicines, Inc. | 0.13% | $226.95K |
| Abivax SA | 0.13% | $224.28K |
| Encompass Health Corp. | 0.13% | $223.29K |
| Ocular Therapeutix, Inc. | 0.12% | $219.97K |
| Belite Bio, Inc. | 0.12% | $215.58K |
| Arrowhead Pharmaceuticals, Inc. | 0.12% | $208.75K |
| Incyte Corp. | 0.12% | $204.84K |
| Immix Biopharma, Inc. | 0.12% | $203.15K |
| Shattuck Labs, Inc. | 0.11% | $197.86K |
| Cullinan Therapeutics, Inc. | 0.11% | $196.67K |
| Sionna Therapeutics, Inc. | 0.11% | $195.98K |
| Parabilis Medicines, Inc. | 0.11% | $195.45K |
| Avalyn Pharma, Inc. | 0.11% | $190.31K |
| BioNTech SE | 0.11% | $186.10K |
| Corvus Pharmaceuticals, Inc. | 0.10% | $184.61K |
| IQVIA Holdings, Inc. | 0.10% | $174.28K |
| Quest Diagnostics, Inc. | 0.10% | $169.56K |
| Tarsus Pharmaceuticals, Inc. | 0.09% | $167.42K |
| Pharvaris NV | 0.09% | $166.81K |
| Tyra Biosciences, Inc. | 0.09% | $166.09K |
| Aktis Oncology, Inc. | 0.09% | $156.77K |
| Disc Medicine, Inc. | 0.09% | $153.30K |
| Olema Pharmaceuticals, Inc. | 0.08% | $148.87K |
| Denali Therapeutics, Inc. | 0.08% | $142.57K |
| Atrium Therapeutics, Inc. | 0.08% | $139.88K |
| Avalo Therapeutics, Inc. | 0.08% | $135.50K |
| Nanobiotix SA | 0.07% | $131.00K |
| Tenax Therapeutics, Inc. | 0.07% | $128.87K |
| Allogene Therapeutics, Inc. | 0.07% | $124.58K |
| Hemab Therapeutics Holdings, Inc. | 0.06% | $111.00K |
| WaVe Life Sciences Ltd. | 0.06% | $109.19K |
| Alto Neuroscience, Inc. | 0.06% | $108.20K |
| Kyverna Therapeutics, Inc. | 0.06% | $105.62K |
| Odyssey Therapeutics, Inc. | 0.06% | $104.23K |
| Adaptive Biotechnologies Corp. | 0.06% | $98.63K |
| SpyGlass Pharma, Inc. | 0.05% | $93.80K |
| Immatics NV | 0.05% | $86.11K |
| Inspire Medical Systems, Inc. | 0.05% | $84.76K |
| Cabaletta Bio, Inc. | 0.05% | $81.61K |
| Celcuity, Inc. | 0.05% | $80.56K |
| Crescent Biopharma, Inc. | 0.04% | $79.45K |
| Evommune, Inc. | 0.04% | $78.85K |
| Iovance Biotherapeutics, Inc. | 0.04% | $76.66K |
| Procept Biorobotics Corp. | 0.04% | $75.12K |
| Agios Pharmaceuticals, Inc. | 0.04% | $73.92K |
| Xencor, Inc. | 0.04% | $71.02K |
| Eikon Therapeutics, Inc. | 0.04% | $66.18K |
| Xenon Pharmaceuticals, Inc. | 0.03% | $54.32K |
| Sensorion SA | 0.03% | $51.63K |
| BioMarin Pharmaceutical, Inc. | 0.03% | $51.50K |
| Entrada Therapeutics, Inc. | 0.03% | $46.85K |
| GE HealthCare Technologies, Inc. | 0.03% | $44.81K |
| Immuneering Corp. | 0.02% | $43.75K |
| Rbc US Govt Money Mkt Fund | 0.02% | $41.19K |
| Bicycle Therapeutics plc | 0.02% | $40.70K |
| Dyne Therapeutics, Inc. | 0.02% | $39.98K |
| BridgeBio Oncology Therapeutics, Inc. | 0.02% | $37.22K |
| Caris Life Sciences, Inc. | 0.02% | $28.14K |
| Aura Biosciences, Inc. | 0.01% | $25.57K |
| MapLight Therapeutics, Inc. | 0.01% | $22.69K |
| Tectonic Therapeutic, Inc. | 0.01% | $18.43K |
| Generation Bio Co. | 0.00% | $2.37K |
| Euro | 0.00% | $506 |
| Danish Krone | 0.00% | $337 |
| Swiss Franc | 0.00% | $245 |
| Swedish Krona | 0.00% | $0 |
| Japanese Yen | 0.00% | $0 |
| Hong Kong Dollar | 0.00% | $0 |
C000203168 overview: performance, fees, allocation and SEC filings